George J Morrow sold $2.2M of Neurocrine Biosciences (NBIX)

Executed Nov 25 2025, disclosed Nov 26 2025, 1 day later.

Value, as filed

$2.2M

15,000 sh × $143.37

Executed

Nov 25 2025

the trade date, as filed

Disclosed

Nov 26 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

GM George J Morrow Director profile →

George J Morrow (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $2.2M of NBIX (15,000 sh × $143.37, as filed), executed Nov 25 2025.

The name

NBIX Neurocrine Biosciences, Inc. NBIX · Healthcare · 59 filings in 24 months ticker →

Healthcare · Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunolog…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→